ZL's protein drug candidate has a long (7 days) half-life time that may allow once a week administration. This is a significant advantage over other drugs. In addition, in human studies it did not cause any detectable side effects or immune reactions. Finally, it can be used with any other anticancer and anti-diabetic drug without the worry of drug interactions.
©2011 ZoltanLabs